Abstract: This invention relates to novel methods and compositions for attracting and controlling the Douglas-fir tussock moth (DFTM). More specifically, this invention pertains to the use of novel pheromone combinations and methods to attract and control DFTM which is a major defoliator of Douglas-fir and other true firs. A composition for manipulating the behaviour of Douglas-fir tussock moths comprising: (a) Z6-heneicosen-11-one (Z6); and (b) one or more compounds from the group consisting of: (Z)6,(E)8-heneicosadien-11-one; (Z)6, (E) 9-heneicosadien-11-one; and (Z)6,(Z)9-heneicosadien-11-one.

Abstract: The invention concerns a transdermal active-substance combination containing phospholipid, alcohol and vitamin E.

Abstract: Disclosed is an agent for curing neuronal diseases caused by disorders of peripheral nervous system or central nervous system, which comprises a 2-acylaminopropanol derivative represented by the formula (I): ##STR1## ?wherein R.sup.1 represents a phenyl group or cyclohexyl group each of which may be substituted by 1 to 3 same or different substituents selected from the group consisting of alkyl, alkoxy, hydroxy and nitro, or represents an alkyl group, and n represents an integer of 0 to 16! or a pharmaceutically acceptable salt thereof as an effective ingredient. It accelerates neurite extension and synapse formation by elevating biosynthesis of endogenous sphingoglycolipid of neurocytes, particularly ganglioside, whereby it can be used for curing various diseases of central nervous system and peripheral nervous system.

Abstract: A whitening cosmetic preparation containing angiogenin as an effective component is disclosed. Angiogenin used in the present invention may be derived from milk, especially bovine milk. The whitening cosmetic preparation contains at least 0.001% by weight, preferably from 0.01 to 20% by weight angiogenin based on the total amount of said preparation. A method for whitening skin comprising administration of angiogenin to skin is also disclosed. The whitening cosmetic preparation inhibits melanin production and prevents the developments of blotches and freckles of skin.

Abstract: Strong reducing chemicals are required by prior art to break disulfide bonds of hair structure in alkaline media. The disulfide bonds are responsible for holding the hair in set condition.This disclosure teaches a new means for breaking the disulfide bonds by use of Tris-(2-carboxyethyl) phosphine (TCEP) in a mildly acid solution.The essence of the specification is the breaking of disulfide bonds in an acid environment.

Abstract: A composition and method for killing insect larvae, in particular, fly larvae, in poultry houses, manure piles, or other sites of habitation are disclosed. The composition consists of one or more C.sub.2 to C.sub.6 aliphatic carboxylic acids or alkali metal, alkaline earth, ammonia, primary, secondary, tertiary, or quaternary ammonium salts in an acceptable formulation for larvacides. The formulation may be applied dry, as an aerosol, or in aqueous or organic solvents.

Abstract: Shaving aids are disclosed comprising at least one active ingredient which provides a physiological cooling effect.

Abstract: This invention provides an antipyretic analgesic preparation having good antipyretic and analgesic effects with reduced adverse effects such as gastrointestinal disorders. The object is achieved by providing a mixture composition containing ibuprofen and isopropylantipyrine. The ratio between them is preferably 5:1 to 1:5, more preferably 3:1 to 1:3, on the weight basis. Preferred dosage forms of the mixture composition are a three-layer tablet comprising an ibuprofen-containing first layer, an isopropylantipyrine-containing third layer, and a second layer composed of one or more inactive ingredients alone as provided between said first and third layers, a dry coated tablet internally having an ibuprofen- or isopropylantipyrine-containing core tablet, and so forth.

Abstract: This invention comprises pharmaceutical compositions consisting essentially of an oil-in-water emulsion containing a synthetic medium chain triglyceride in which is dissolved a therapeutically effective amount of a cyclosporin, phospholipid and optionally free fatty acid or a salt thereof, non-ionic surfactant, ionic surfactant, glycerol, salts, buffers, preservative, osmotic modifier and antioxidant.